finance.yahoo.comNov 10$PAYS

Paysign (PAYS) Q3 2026 Earnings Call Transcript

Paysign (PAYS) reported Q3 2026 earnings, highlighting growth in its patient affordability business with revenue doubling to $16.6M YoY. Plasma revenue rose 7.5% to $13.8M. The company expects to offset a loss of 113 plasma centers with new clients. Patient affordability drove strong margins and operating leverage, while Apherion, a plasma industry software, is under regulatory review.

Original reporting

finance.yahoo.com

Published Nov 10, 2026, 6:47 AM UTC

Analysis

AlphAI AI DeskAI-generated

Added to AlphAI Nov 10, 2026, 7:05 AM UTC. Informational, not investment advice.

How this was made

AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About AlphAI AI Desk Scoring methodology Report an issue

Paysign (PAYS) Q3 2026 Earnings Call Transcript — source image — Source · finance.yahoo.com

Decision brief

The 30-second read

$PAYSBullishMed

Why it matters

Earnings beat and margin growth could attract investors seeking exposure to healthcare fintech.

Market read

Strong earnings may drive short-term price appreciation for PAYS and influence related healthcare fintech stocks.

What to watch

Potential regulatory review of Apherion could delay European expansion.

Relevance 8/10Novelty 8/10Timing: Q3 2026 earnings release

Background

Paysign provides patient affordability solutions and plasma processing services, reporting Q3 2026 results.

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$PAYSBullishHigh confidence

Context

Q3 2026 earnings call disclosed revenue doubling in patient affordability, margin expansion and operating leverage, plus a 7.5% plasma revenue increase.

Expected impact

likely upside as market prices in better-than-expected earnings and raised guidance

Evidence & confidence

Revenue and margin numbers exceed guidance; operating margin tripled to 23.8%, indicating robust profitability.

Market effects

Sector

Patient affordability growth may boost related pharma service providers and healthcare technology stocks.

Regional

U.S. healthcare sector could see modest gains from Paysign's strong results.

Global

Limited to healthcare and fintech segments; no broad market impact.

Counterpoint

What could challenge this read

Margin expansion may be temporary if plasma client transition reduces cash flow in Q4.

Key entities

company
Paysign
U.S.-listed provider of patient affordability and plasma processing services.

Read at source ← All news

$PAYSHigh

Paysign Reports Record Third Quarter 2026 Revenue of $30.8 Million, Up 43%; Operating Margin More Than Triples to 23.8%

Paysign, Inc. (PAYS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Earnings Release Paysign Reports Record Third Quarter 2026 Revenue of $30.8 Million, Up 43%; Operating Margin More Than Triples to 23.8% Patient Affordability Growth Drives Revenue and Margin Expansion Raises Full Year 2026 Gross Margin, Net Income, GAAP EPS and Adju

SEC EDGAR 8-KNov 9

$PAYSHigh

Paysign Reports Record Second Quarter 2026 Revenue of $28.3 Million, Up 48%; Raises Full-Year Outlook

Paysign, Inc. (PAYS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Earnings Release Paysign Reports Record Second Quarter 2026 Revenue of $28.3 Million, Up 48%; Raises Full-Year Outlook Growth Driven by Continued Momentum in Plasma and Patient Affordability Businesses Mix Shift and Expense Discipline Continue to Drive Gross and Oper

SEC EDGAR 8-KAug 5

$TEOMedAI 8/10

Telecom Argentina Stet - France Telecom Q3 Earnings Call Highlights

Telecom Argentina (NYSE:TEO) reported Q3 capital expenditures of $350M, with net debt decreasing 9% YoY to $2.9B. 5G sites expanded to 1,900. Postpaid mobile lines grew 1% YoY, broadband increased 2.5%, and pay TV grew nearly 5%. EBITDA margin excluding TMA exceeded 42%. The company agreed to a $400M divestment with Metrotel, aiming for future integration.

finance.yahoo.comNov 15

LowAI 8/10

CoreWeave’s Results Foretell Impending Consolidation In AI Neocloud Sector

CoreWeave reported record Q3 revenue of $3.66B, up 168% YoY, and raised its full-year outlook. However, it also reported a net loss of $709M, $846M in interest expense, and plans $39B in 2026 capex. Its debt grew to $46.8B by Q3 2026. CoreWeave's growth relies on significant financing, raising concerns about the neocloud business model's sustainability and potential consolidation.

finance.yahoo.comNov 15

$CRDOMed

Credo Technology outpaces Broadcom in AI networking growth

Credo Technology Group reported fiscal 2026 revenue of $1.3B, up 206% YoY, with non-GAAP EPS rising 392% to $3.46. The company's growth is driven by AI networking products, including active electrical cables. Credo's stock gained 74% YTD. Broadcom's AI chip revenue grew 221% YoY to $16.7B in one quarter. Credo expects over 80% revenue growth in fiscal 2027, with optical revenue exceeding $600M.

cryptobriefing.comNov 15

$RYAAYMedAI 8/10

Wizz Air's Profit Fell 67%. Ryanair's Fell Just 15%

Wizz Air's H1 profit fell 67% to €108.1M on 14% revenue growth, while Ryanair's profit dropped 15% to €2.15B on 3% revenue growth. Wizz faced higher fuel costs and grounded aircraft, while Ryanair benefited from better fuel hedging and fleet management. Both airlines cited fuel costs as a major factor.

liveandletsfly.comNov 15